Stockholders' Deficit (Detail) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 15, 2025	Jun. 16, 2024	Jun. 15, 2025	Jun. 16, 2024
Stockholders' Deficit [Line Items]
Balance			$ (3,962,291)
Net Income (Loss)	$ 131,091	$ 141,978	280,742	$ 267,802
Balance	$ (3,974,627)		$ (3,974,627)
Common Stock [Member]
Stockholders' Deficit [Line Items]
Balance (in shares)	34,230,813	34,801,757	34,281,927	34,726,182
Balance	$ 342	$ 348	$ 343	$ 347
Issuance and cancellation of stock awards, net (in shares)	3,654	17,616	58,170	61,669
Issuance and cancellation of stock awards, net				$ 1
Tax payments for restricted stock upon vesting, (in shares)	(673)	(5,175,000)	(19,303)	(20,388)
Purchases of common stock, shares	(315,696)		(430,976)	(56,372)
Purchases of common stock, value	$ (3)		$ (4)	$ (1)
Exercises of stock options, (in shares)	19,124	142,425	47,404	245,532
Exercises of stock options		$ 2		$ 3
Balance (in shares)	33,937,222	34,956,623	33,937,222	34,956,623
Balance	$ 339	$ 350	$ 339	$ 350
Additional Paid-in Capital [Member]
Stockholders' Deficit [Line Items]
Balance	892	1,191	1,272	2,801
Tax payments for restricted stock upon vesting	(314)	(2,560)	(8,472)	(9,260)
Purchases of common stock, value	(15,500)		(25,632)	(17,021)
Exercises of stock options	4,790	20,691	12,319	31,464
Non-cash equity-based compensation expense	10,975	10,686	21,356	22,024
Balance	843	30,008	843	30,008
Retained Deficit [Member]
Stockholders' Deficit [Line Items]
Balance	(3,906,833)	(4,004,877)	(3,956,474)	(4,069,648)
Net Income (Loss)	131,091	141,978	280,742	267,802
Dividends declared on common stock and equivalents	(59,457)	(53,109)	(119,257)	(106,063)
Purchases of common stock, value	(135,983)		(176,193)	(8,099)
Balance	(3,971,182)	(3,916,008)	(3,971,182)	(3,916,008)
Accumulated Other Comprehensive Loss [Member]
Stockholders' Deficit [Line Items]
Balance	(7,089)	(4,992)	(7,432)	(3,867)
Currency translation adjustment	2,462	(483)	2,805	(1,608)
Balance	$ (4,627)	$ (5,475)	$ (4,627)	$ (5,475)